Procter & Gamble Hygiene and Health Care Limited
PGHH · FMCG · NSE
₹9,845
Current Market Price
Fair Value (DCF)
₹9,376
Margin of Safety
-4.8%
Updated just now
YieldIQ Score
36/100
Piotroski F-Score
8/9
Economic Moat
Moderate
Confidence
33%
ROE
10.5%
Debt/Equity
0.00
WACC
9.8%
Market Cap
₹0.32 Lakh Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
110.1%
Return on capital employed
EV / EBITDA
26.0×
Enterprise multiple
Debt / EBITDA
0.0×
Leverage vs earnings
Interest Coverage
35.8×
EBIT covers interest
Current Ratio
1.22×
Short-term liquidity
Asset Turnover
2.03×
Revenue per ₹ of assets
Revenue CAGR (3Y)
—
3-year revenue growth
Revenue CAGR (5Y)
7.6%
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹9,845
Bear case
₹5,906.63
MoS -66.7%
Base case
₹9,375.71
MoS -5.0%
Bull case
₹11,869.49
MoS +17.1%
Ratio Trends
PGHH · last 6 annual periods
ROE
10.5%
ROCE
14.5%
Operating Margin
—
Debt / Equity
—
PE
303.6×
EV / EBITDA
49.4×
Historical Financials
PGHH · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹3002 Cr | ₹3574 Cr | ₹776 Cr | ₹853 Cr | ₹932 Cr | -25.4% |
| EBITDA | — | ₹924 Cr | ₹854 Cr | ₹909 Cr | ₹1023 Cr | +2.6% |
| EBIT | ₹600 Cr | ₹876 Cr | ₹58.5 Cr | ₹210 Cr | ₹112 Cr | -34.2% |
| PAT | ₹433 Cr | ₹652 Cr | ₹42.5 Cr | ₹151 Cr | ₹81.1 Cr | -34.2% |
| EPS (diluted) | ₹133.42 | ₹200.79 | ₹13.11 | ₹46.59 | ₹24.97 | -34.2% |
| CFO | — | ₹863 Cr | ₹573 Cr | ₹826 Cr | ₹471 Cr | -14.1% |
| CapEx | — | — | — | — | — | — |
| FCF | — | — | — | — | — | — |
| Total Assets | — | ₹1633 Cr | ₹1681 Cr | ₹2137 Cr | ₹1859 Cr | +3.3% |
| Total Debt | — | — | ₹0.0 Cr | ₹0.0 Cr | ₹0.0 Cr | — |
| Shareholders' Equity | — | — | ₹738 Cr | ₹946 Cr | ₹775 Cr | +1.2% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
PGHH vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| GILLETTE GILLETTE | — | — | Pending | 11.9% | — |
| COLPAL Colgate Palmolive (India) Limited | -14.8% | 33 | Fairly valued | 86.3% | 45.2× |
| DABUR Dabur India Limited | -7.0% | 30 | Fairly valued | 15.8% | 50.8× |
| MARICO Marico Limited | -36.3% | 31 | Overvalued | 38.2% | 51.8× |
| GODREJCP Godrej Consumer Products Limited | -39.6% | 43 | Overvalued | 15.4% | — |
Click a ticker to view its fair-value analysis.
Dividend History
19 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹1,200.00/sh
Last payout
2026-02-05
₹195.00
Peak payout
₹362.00
Trailing yield
2.64%
Amounts parsed from NSE subject lines; percent-of-face-value declarations are not converted and shown as missing.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. Procter & Gamble Hygiene and Health Care Limited (PGHH.NS) trades at 9845.00 vs a model fair value of 9375.71, a gap of -4.8%. Piotroski ...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of PGHH →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for PGHH →
Compare
Head-to-head with peers
Compare PGHH side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse PGHHNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.